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Structural details of changes accompanying interaction between insulin-related
hormones and their binding partners are often enigmatic. Here, cross-linking/mass
spectrometry could complement structural techniques and reveal details of these protein-
protein interfaces. We used such approach to clarify missing structural description of the
interface in human insulin-like growth factor (IGF-1): Drosophila melanogaster imaginal
morphogenesis protein-late 2 protein (Imp-L2) complex which we studied previously
by X-ray crystallography. We crosslinked these proteins by heterobifunctional cross-
linker sulfosuccinimidyl 4,4′-azidopentanoate (Sulfo-SDA) for the subsequent mass
spectrometry (MS) analysis. The MS analysis revealed IGF-1:Imp-L2 interactions which
were not resolved in the crystal structure of this assembly, and they converged with X-ray
results, indicating the importance of the IGF-1 N-terminus interaction with the C-terminal
(185–242) part of the Imp-L2 for stability of this complex. Here, we also showed the
advantage and reliability of MS approach in solving details of protein-protein interactions
that are too flexible for solid state structural methods.
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INTRODUCTION
The insulin/insulin-like growth factor signaling axis is an evolutionary ancient and highly
conserved hormonal system involved in the regulation of metabolism, growth and lifespan in
animals. In humans this axis contains insulin and two insulin-like growth factors (IGF-1 and IGF-
2) eliciting their function through activation of tyrosine kinase-type receptors (1). Secretion of
insulin from pancreatic β-cells is regulated in response to blood glucose levels. Subsequently, the
active monomeric form of this hormone circulates freely in the blood and is readily cleared away in
minutes. In contrast, IGFs are secreted by many tissues in endocrine or paracrine mode and their
bioavailability is controlled by several IGF binding proteins (IGFBP 1–6) (2) and the non-signaling
IGF-2/mannose-6-phosphate receptor (3). There are also IGFBP-related proteins (IGFBP-rP) that
carry the N-terminal domain of IGFBPs hence are classified as part of the IGFBP superfamily.
However, IGFBP-rPs have low or no affinity for IGFs/insulin, and their functions are not fully
elucidated being, most probably, IGF/insulin independent (4).
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In invertebrates various insulin-like peptides (ILP) were
discovered, which production and secretion depend on food
availability and developmental stage, and, in contrast to humans,
they signal through only one insulin receptor-like receptor (5).
The bioavailability of ILPs ismost probably influenced also by ILP
binding proteins (IBP). Although proteins related to the IGFBP-
rPs were also identified in Crustacea and reported to bind an ILP
responsible for sexual differentiation (6), proteins corresponding
to the “true” vertebrate IGFBP 1–6 were not identified in
invertebrates. Instead, it seems that the function of IGFBPs is
fulfilled by IBPs which are composed of two immunoglobulin-
like (Ig) domains and bind ILPs (including human insulin and
IGF-1) with nanomolar affinities (7). Recently, we solved the apo
and holo crystal structures of 242 amino acidDrosophila imaginal
morphogenesis protein-late 2 protein (Imp-L2) which is one of
the insect IBPs (7). We have shown that the ligand (Drosophila
ILP5 and human IGF-1) binding mode of Imp-L2 differs from
that of IGFBPs. The hormone accommodates its B-helix across
Imp-L2 inter-domain β-sheet, facilitating also a new arrangement
of this IBP (Figure 1A) In contrast, human IGFBPs bind IGF-1
in the cleft between IGFBP N-terminal and C-terminal domains
(Figure 1B) (2).
There have been recently very significant breakthroughs
in structural description of insulin/IGFs:receptors interactions
and their changes upon signal transduction (8, 9). However,
despite all advances in structural biology, the insulin/insulin-
like signaling axis contains plethora of very mobile, or
disordered, protein interfaces that appear disordered and escape
characterization. For example the end of the B-domain, the whole
C-domain, and D-domain in IGF-1 were/are untraceable in the
complexes of IGF-1 with its binding partners (7, 8).
Structural mass spectrometry (MS) approaches find
applications in determination of protein-protein contacts
and for structural analysis (10). There is an increasing use of
chemical crosslinking in structural MS approaches that use
bifunctional reagents to covalently connect interacting partners,
or protein chains, located in a distance defined by the arm of
the chemical linker (11). One of them: sulfo-succinimidyl 4,4′-
azidopentanoate (Sulfo-SDA) is a heterobifunctional cross-linker
that contains an amine-reactive N-hydroxysuccinimide ester
and a photoactivable diazirine ring. The photoactivation of the
Sulfo-SDA leads to a reactive carbene intermediate that reacts
with any amino acid side chain or peptide backbone within the
spacer arm distance (3.9 Å). We selected heterobifunctional
SDA as it allows a sequential reaction–thus eliminating
unwanted intramolecular crosslinking, and due to its non-
selective, versatile characters; it is expected to react at the site of
interaction regardless the availability of specific reactive group.
However, regardless the progress in MS methods, identification
of crosslinked species is still a challenging task. The crosslinked
peptides have higher charges and are overall less abundant in
the background of linear peptides. Also, a low specificities of
photo-inducible cross-linkers complicate the MS analysis even
further (12).
Our previous crystallographic studies on the holo Imp-L2
revealed the importance of Imp-L2 C-terminal (∼168–242)
region for specific binding of the hormones, including IGF-1.
FIGURE 1 | (A) The crystal structure of Imp-L2:IGF-1 complex (PDB ID 6FF3).
Imp-L2 Ig-NT and Ig-CT domains are in gray and green, respectively, and
IGF-1 with its numbering is in magenta; A–G refer to the β-strand
nomenclature as in Roed et al. (7). Some parts of these proteins relevant to
this work and unobserved in the crystal structure: 1–19 for the Imp-L1 and
22–42 for the IGF-1, are depicted as dashed lines (not up to a possible real
scale); IGF-1 D-domain (63–70), also not visible in the complex and not
present in the des(63-70)-IGF-1 analog is omitted for figure clarity. (B)
IGF-1:IGFBP-4 complex (PDB ID 2DSR). The IGFBP N- and C-domains, and
IGF-1 are in gray, green, and magenta, respectively.
We also observed IGF-1 N-terminus in a new, never previously
described in this hormone, α-helical (so-called R) conformation.
However, some of the Imp-L2 side chains that could form
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tighter interactions within the IBP region and contribute to the
stabilization of this conformation, were disordered. Therefore,
we explored the MS approach with the use of Sulfo-SDA toward
identification of crosslinked peptides derived from IGF-1:Imp-
L2 complex interface, in order to investigate the in-solution
proximity of these, possibly, structurally important side-chains,
and to verify our previous observation.
MATERIALS AND METHODS
Production of Recombinant Proteins
Human IGF-1 was purchased from Tercica Inc. Human
IGF-1 lacking the C-terminal D domain amino acids
PLKPAKSA (des(63-70)-IGF-1) (IGF-1 UniprotKB entry
P05019, amino acids 49–110) was cloned similarly to
our previous work (13). Briefly, modified pRSFDuet-
1 harboring Gly-1-IGF-1 was amplified by PCR using
ACYCDuetUP1 (5′-GGATCTCGACGCTCTCCCT−3′)
and IGF-1del PLKPAKSA Rev (5′-
GCAGGTGAATTCATTACGCGCAATACATTTCCAG−3′)
primers and cloned back into NcoI/EcoRI sites of pRSFDuet-1.
Expression from cloned construct produces des(63-70)-IGF-1 as
a fusion with an N-terminal His6 tag, GB1 protein and tobacco
etch virus (TEV) protease cleavage site (Glu-Asn-Leu-Tyr-Phe-
Gln↓Gly). Des(63-70)-IGF-1was created with an additional
N-terminal Gly-1 to facilitate TEV cleavage. Des(63-70)-IGF-1
was produced in E. coli BL21(DE3), purified and characterized as
previously published (14).
Recombinant Drosophila neural/ectodermal development
factor Imp-L2 was produced as described previously (7).
Shortly, Imp-L2 cDNA was sub-cloned to PVL1392 plasmid
(BD Biosciences). Recombinant FlashBAC virus was prepared
after transfection of SF21 cells (Invitrogen). High Five cells
(Invitrogen) were infected with the virus for a large-scale
production of the protein. Imp-L2 was purified using Strep-
Tactin column and the Strep-tag II was removed by HRV14
3C protease.
Modification of Ligands by Sulfo-SDA and
Photocrosslinking
Human IGF-1 or des(63-70)-IGF-1were modified with sulfo-
succinimidyl 4,4′-azidopentanoate (Sulfo-SDA, ThermoFisher).
Proteins (0.2mM, about 100 µg) in PBS were incubated with
2mM Sulfo-SDA for 2 h on ice. The reaction was stopped by
addition of a quenching Tris/HCl buffer (pH 8) to a final
40mM concentration. The mixture was incubated 5min at room
temperature. Modified proteins in PBS (final concentration about
0.1mM) were separated from unreacted crosslinker using Zeba
Spin Desalting Column (ThermoFisher).
Ligands (about 100 µg, 10–20 nmol) modified with Sulfo-
SDA on their Lys and N-terminal amines were incubated with
recombinant Imp-L2 (76 µg, about 3 nmol) overnight at 4◦C.
Proteins were photocrosslinked using irradiation at 365 nm for
5min in a distance 1 cm from the light source (UVP Black-Ray
B-100AP Lamp, Fisher Scientific).
Samples after photocrosslinking were analyzed using SDS-
PAGE (14% gel). The extent of crosslinking of IGF-1 and des(63-
70)-IGF-1 to Imp-L2 was determined using western-blotting
with anti-IGF-1 antibody (1C5-1A2) (MA1-088, ThermoFisher).
Mixture of proteins after photocrosslinking was separated on
SDS-PAGE and stained with Coomassie R250. Bands containing
the unmodified proteins and bands containing the crosslinked
product were excised.
MALDI-TOF/TOF
Small samples of ligands (about 10 µg, 1–2 nmol) modified with
SDA were irradiated at 365 nm for 5min in a distance 1 cm
from the light source (UVP Black-Ray B-100AP Lamp, Fisher
Scientific). Extent of modification of available amino groups with
diazirine arm was controlled using UltrafleXtremeTM MALDI-
TOF/TOF (Bruker Daltonics). SDA-modified IGF-1 (0.025mM)
was also incubated with high concentration of free amino
acid (0.1M glycine), with a tetra peptide (10mM GFFMetF-
amide) or with a peptide TFEDYLHNVVTVPRPS (0.1mM)
and irradiated.
Samples were prepared by dried droplet method. Both,
unmodified and SDA-modified ligands were diluted in 50%
ACN and 0.1% TFA (10 pmol/µL). Saturated DHB matrix
solution (50% ACN, 0.1% TFA) was prepared. The matrix
solution was mixed in equal volumes with the sample solution.
The mixture was pipetted on the target (1 µL) and dried at
ambient temperature.
IGF-1 and des(63-70)-IGF-1 were measured in linear mode,
instrumental setting tuned to 2–20 kDa. The accelerating
voltage was set at 25 kV. Typically, spectra were obtained by
accumulating 5,000 shots.
MS/MS
Bands corresponding to crosslinked protein were excised from
the SDS-PAGE gels and distained. Cysteines were reduced
with 50mM DTT for 45min at 60◦C and free cysteines
were alkylated with 100mM iodoacetamide for 30min at
room temperature in the dark. Trypsin digestion proceeded
overnight at 37◦C with an enzyme/protein ratio of 1:20 (w/w).
Peptides extracted from the gel were loaded on a trap column
(ZORBAX 300SB-C18, 5µm, 5 × 0.3mm, Agilent, Santa
Clara, CA) and desalted for 5min at flow rate 20 µL/min.
Peptides were then separated by reversed phase C18 column
(ZORBAX SB C18 RR 3.5µ 150 × 0.3mm, Agilent, Santa
Clara, CA) at a flow rate 10 µL/min using capillary HPLC
system (Agilent Technologies) under the following gradient
conditions: 1–10% B in 1min, 10–45% B in 19min, 45–
95% B in 5min, where solvent A was 0.1% formic acid,
2.0% acetonitrile in water and solvent B was 0.1% formic
acid in 98% acetonitrile. The column was heated at 50◦C
and connected directly to an 15T solariX FT-ICR mass
spectrometer (Bruker Daltonics) using an electrospray ion
source. The instrument was on line calibrated resulting in mass
accuracy below 2 ppm. Data acquisition and data processing
were performed by ftmsControl 2.1.0 and DataAnalysis 4.2
(Bruker Daltonics).
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FIGURE 2 | Amino-acid sequences of IGF-1 (top) and des(63-70)-IGF-1 (bottom). IGF-1 domains are highlighted by background colors (B domain yellow, A domain
blue, C domain gray and D domain violet). Trypsin cleavage sites and expected peptides are shown. Peptides containing amino acid residues with primary amines
(red) susceptible to succinimide reaction are named N-terminal, B-C and A-D.
Strategy for Identification of Crosslinked
Peptides
MS spectra were searched for peptides corresponding to the
sequence of Imp-L2 and IGF-1 or des(63-70)-IGF-1 using
Links software (15). The Links algorithm was set to consider
the carbamidomethylation of cysteine and the possible single
oxidation of methionine. The mass error threshold was kept
below 2 ppm and assigned fragments were verified manually.
Crosslinked peptides were searched between the two sequences
as N-terminus or Lysine connected anywhere by an arm with
molecular mass +82.0419 Da (16). Suggested crosslinks found
in several (n ≥ 4) successive scans were considered as reliable
and the spectra were manually searched for theoretical MS/MS
fragments of peptides originating from the two proteins.
Further, the data were exported to mgf format and
loaded into the StavroX software (version 3.6.0.1). The cross-
linked peptides were searched using following parameters:
fixed caramidomethylation of cysteines, variable oxidation
of methionines, specificity of SDA for site 1 “K,S,T,Y,”
specificity for site 2 “A,I,L,M,S,T,W,H,D,E,N,K,P,G,V,Q,m,C,B”
(where “m” represents oxidized methionine and “B” represents
caramidomethylated cysteine). Precursor precision was set to 2.0
ppm and fragment ion precision was set to 20.0 ppm. FDR cut
off was below 5%. Decoy analysis was performed by shuffling
fasta database while keeping the amino acids of protease sites in
place (17).
RESULTS
Photocrosslinking of IGF-1 or
des(63-70)-IGF-1 to Imp-L2
We prepared the IGF-1 lacking the D domain residues
PLKPAKSA (des(63-70)-IGF-1) with the aim to reduce the
number of primary amines available for reaction with the
succinimide ester in Sulfo-SDA and thus simplify theMS analysis
(Figure 2). Also, an additional N-terminal glycine residue
Gly(-1) was incorporated into IGF-1 to facilitate production of
des(63-70)-IGF-1 (13).
The extent of modification of the wt and truncated IGF-
1 by SDA was tested using MALDI-TOF/TOF (Figure 3).
The SDA-modified IGF-1 yielded triple modified product
and, in slightly lower amount, quadruple modified IGF-1
as well (Figure 3C). As expected, the prevailing products of
the des(63-70)-IGF-1 modification were only double modified
species with two diazirine arms (Figure 3D). Species with
higher extend of modification that are observed in the
chromatograms (Figures 3C,D) resulted from limited reactivity
of N-hydroxysuccinimide ester with hydroxyl group in side
chains of serines, threonines, and tyrosines.
To check specificity of the crosslinking reaction, we performed
control experiments where SDA-modified IGF-1 was incubated
with excess of free amino acid/test peptides and irradiated.
MALDI-TOF/TOF analysis was used to search for the products.
Either alkene or alcohol were formed (same as in Figure 3C)
after irradiation of diazirine, and no visible crosslinked products
were detected in these experiments despite high concentration
of peptides.
Efficiency of Imp-L2 crosslinking reactions with IGF-1
and des(63-70)-IGF-1 were analyzed using SDS-PAGE and
western-blot. Unreacted hormones and Imp-L2, together with a
crosslinked product, were clearly visible on the Coomassie blue
stained gels. The crosslinked product was detected with an IGF-1
antibody (Figure 4). Only about 10–20% of the starting amount
of Imp-L2 was crosslinked to the hormones in both, IGF-1 and
des(63-70)-IGF-1 reactions.
Identification of Crosslinked Peptides
Crosslinked peptides were searched using Links algorithm
(dealing with MS data) and StavroX software (dealing with
MS/MS data). Both approaches identified the same crosslinks.
The results are shown in Supplementary Material (“StavroX
results for crosslinks between IGF-1 or des (63-70)-IGF-1 and
Imp-L2.pdf” and “Links results for crosslinks between IGF-1
or des(63-70)-IGF-1 and Imp-L2.xlsx”). Crosslinked peptides
are listed in Table 1 for des(63-70)-IGF-1:Imp-L2 complex and
in Table 2 for IGF-1:Imp-L2 complex and diagrams showing
fragments observed in respective MS/MS spectra of each peptide
are drawn in Figure 5.
As expected, the crosslinking of des(63-70)-IGF-1 provided
simpler data and was considered as decisive when assessing the
Links data of IGF-1 analysis (see Supplementary Material). Only
the crosslinks found in multiple successive scans and confirmed
by manual searches for MS/MS fragments were considered as
reliable. The other hits were excluded as false positive. All
the selected identified crosslinks were subsequently also found
through automated StavroX analysis.
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FIGURE 3 | MALDI-TOF/TOF analysis of (A) IGF-1 and (B) des(63-70)-IGF-1 after coupling with Sulfo-SDA. Carbene was formed after irradiation of diazirine moiety
and was either eliminated by formation of double bound resulting in the increase of Mr of about 82 Da or it reacted with one molecule of water resulting in the increase
of Mr of about 100 Da. (C) SDA modified IGF-1. (D) SDA modified des(63-70)-IGF-1.
We have not identified any reliable crosslinked product of
Lys residues within the IGF-1 D domain. Although there were
multiple suggested crosslinks in the Links search none fulfilled
the criteria of reliability, and no ions confirming the crosslink
were found. No potential crosslinks in D domain were identified
using the StavroX. The D domain probably did not contribute to
the ligand interaction.
The des(63-70)-IGF-1 N-terminal Gly(-1) was found to
be bound to Imp-L2 peptide 178–188 (AEITWLNNENK).
Identical crosslinked peptide was found for IGF-1:Imp-L2
experiment (Figure 6). We observed the b6 ion of peptide
178–188 Imp-L2 which would suggest that the crosslink was
formed within the sequence 184–188 of Imp-L2 (Figure 5
and Supplementary Material). This finding corresponds to the
crystallography data as IGF-1 Gly1 is very close to Imp-L2
Asn185 (∼4.3 Å) and Glu186 (∼4.5 Å) (Figure 6B).
Besides, other contacts of IGF-1 Gly1 were found (Table 2
and Figure 6B). The N-terminal peptide was crosslinked to
the peptide 211–218 (WEDMGNYK) which was identified as
major binding interaction site in the X-ray structure. It was
also crosslinked to peptide 142–150 (TYPGAQKPR). All three
Imp-L2 peptides found to be crosslinked to IGF-1 N-terminus
form neighboring β-strands A, G, and F (Figures 1A, 6B) of
Imp-L2 Ig C-terminal domain.
Next, we identified crosslinked peptide
connecting IGF-1 23–36 with Imp-L2 peptide 2–24
(AVDLVDDSNDVDNSIEAEEEKPR) (Tables 1, 2, Figure 5
and Supplementary Material). The crosslinked peptide
was identified in both IGF-1:Imp-L2 and des(63-70)-IGF-
1:Imp-L2 crosslinking experiments. The 22–44 region of
IGF-1 and the N-terminal part of Imp-L2 (1-29) were
not visible in the crystal structure despite their spatial
proximity (Figure 1A) (7). However, a high number of
scans (see Supplementary Material) in which this crosslinked
peptide was identified suggests its relative abundance and,
consequently, would indicate strong interactions within
these sequences. As shown in our experiments with test
peptides, the carbene formed upon photoactivation of
diazirine would react readily with water to create alcohol,
or rearrange to give an alkene if there is no close contact with
an interacting partner thus reducing the yield of the crosslinking
reaction (16).
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FIGURE 4 | SDS-PAGE and western blot analysis of photocrosslinked IGF-1 or des(63-70)-IGF-1 to Imp-L2. Imp-L2 (line 1) was photocrosslinked to SDA-modified
IGF-1 (line 2) or des(63-70)-IGF-1 (line 3). Samples were resolved by SDS-PAGE on 14% gels and stained either by Coomassie blue or blotted to PVDF membrane
and detected with anti-IGF-1 antibody (1C5-1A2) (MA1-088, ThermoFisher). Molecular weight standards (BioRad) are shown in line 4.
TABLE 1 | Crosslinked peptides between des(63-70)-IGF-1 and Imp-L2.
Crosslinked peptide (des(63-70)-IGF-1)–(Imp-L2) Exp. mass Thr. mass Error StavroX score
(−1, 21)–(178, 188) 3776.7892 3776.7894 −0.06 67
(22, 36)–(2, 24) 4307.9865 4307.9851 +0.31 103
TABLE 2 | Crosslinked peptides between IGF-1 and Imp-L2.
Crosslinked peptide (IGF-1)–(Imp-L2) Exp. mass Thr. mass Error StavroX score
(1, 21)–(178, 188) 3,719.7681 3719.7680 −0.04 79
(1, 21)–(211, 218) 3430.5381 3430.5388 −0.2 24
(1, 21)–(142, 150) 3405.6567 3405.6566 +0.03 61
(22, 36)–(2, 24) 4307.9859 4307.9851 +0.19 41
DISCUSSION
Structural mass spectrometry (MS) approaches find utilization
in determination of protein-protein contacts and for structural
analysis. We aimed to explore the cross-linking/mass
spectrometry approach toward revealing the in-solution
proximity of protein-protein interface. We utilized a IGF-
1:Imp-L2 complex that we previously studied using X-ray
crystallography. The knowledge of the structure allowed us to
critically evaluate reliability of crosslinked peptides proposed
by the scoring algorithm of MS spectra but also to verify our
previous observation. To simplify the MS analysis we prepared
the IGF-1 lacking the D domain. As anticipated, theMS spectrum
of des(63-70)-IGF-1 crosslinked to Imp-L2 was simpler, clearer
and contained less false-positive hits compared to the IGF-
1:Imp-L2 spectrum. Nevertheless, identical crosslinked peptides
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FIGURE 5 | Diagrams of identified crosslinked peptides (A) between IGF-1:Imp-L2 and (B) between des(63-70)-IGF-1:Imp-L2. MS/MS fragments and sites of
crosslinks found in StavroX search are shown in blue. Manually assigned fragments confirming crosslinks suggested by Links algorithm are shown in violet.
were identified for both wt and truncated IGF-1 bound to
Imp-L2 which further supported reliability of the approach.
We previously described a unique R-state like rearrangement
of N-terminus of IGF-1 firmly anchored to Imp-L2 β-
sheet surface in the IGF-1:Imp-L2 crystal structure (7). This
arrangement was supported by the crosslinking experiments
(Figure 6) where we identified the N-terminal peptide of IGF-1
crosslinked to the C-terminal part of Imp-L2.
Surprisingly the most distinctive crosslinked peptide was
found within the N-terminal peptide 2–24 of Imp-L2 and 23–
36 region of IGF-1. These parts of the proteins were not
observed in the crystal structure. This would suggest that they
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FIGURE 6 | (A) Amino acid sequence of Imp-L2. Peptides crosslinked to IGF-1and des(63-70)-IGF1 are highlighted by background colors (IGF-1 peptide (22–36)
green and N-terminal peptide yellow for both ligands and orange for IGF-1). Key residues for hormone binding observed in holo-Imp-L2 structure are indicated by red
stars (7). (B) Some of the des(63-70)-IGF-1:Imp-L2 contacts identified in this work and in the crystal structure (PDB ID 6FF3) of this complex. IGF-1 and Imp-L2 are in
magenta and green, respectively; sulfur atoms in yellow, oxygen in red, nitrogens in blue; hydrogen bonds and close Van der Waals contacts as black dashed lines,
and putative inter-atom contacts relevant for this work are in green dashed lines.
may contribute to IBP:hormone complex formation but such
interaction is transient due to mobility of this region. We have
previously shown that the increase of the separation of Imp-
L2 N-(1-30) and C-termini (236–238) upon hormone binding
allows the expansion of the β-sheet surface in its holo crystal
structure. We also postulated that the 1–16 polypeptide of the
Imp-L2 (unobserved in the crystal structure) is involved in
triggering of the apo → holo transition upon “pressure” from
the incoming hormone. This subsequently involves increased
contacts between N-termini and 70–90 loop of the Imp-L2, and
formation of newly arranged Imp-L2 dimer with broad hormone-
binding surfaces (7). Here, our crosslinking MS data confirm
the predicted “hormone sensing” role of 1–16 N-terminal part
of the Imp-L2, which occurs in concert with similar, but more
directional and contact specific, hormone:Imp-L2 C-terminus
interactions. However, much lower sequence similarity of the N-
terminal (∼1–30) part of insects IBPs (7) in comparison with
rather conserved C-termini of these proteins suggest different
roles of these hormone:IBP contacts. For example, hormone:IBP
N-terminus interactions may be responsible for the initiation of
the formation of this complex and priming IBP for an effective
engagement with the ligand (“entropic” contribution), while
hormone:IBP C-terminus contacts assure firmness/stability of
this complex (“enthalpic” contribution).
Photo-crosslinking has already been used in mapping the
interactions of ligands (insulin/IGF) with their receptors and
binding proteins (18, 19). The incorporation of para-azido-Phe
photo-probe into hormones was employed. In addition, the
hormones had to be specifically labeled, mostly biotinylated,
to enable detection of the site of crosslink after partial
proteolysis. Although these studies provided substantial input
toward our understanding of hormone:receptor binding, these
experiments were rather complex, and allowed mainly only
an approximate estimation of the site of crosslink (19). Our
work presented here shows that the MS based techniques
may surpass, to great extent, such obstacles although they
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still present some—but different–limitations. It seems that the
main bottleneck here is the detection and identification of
the crosslinked peptides. The applications of various scoring
procedures with statistical methods in automated data analysis
does not prevent misassignment of the crosslinked products
(12). To address this issue we utilized our knowledge of
the mass of the crosslinker arm and the span/length of the
expected peptides originating from the ligand. These were
exploited in the input for the search of reliable outputs,
allowing us to eliminate some false-positive hits. Obtained
crosslinked peptides were confirmed by MS/MS data. However,
even though crosslinked proteins were separated on SDS-
PAGE, the abundance of crosslinked peptides in the spectra
was low. Consequently the suggested sites of crosslink given by
StavroX (Figure 5) should be considered with caution as MS/MS
sequence coverage of the peptides was insufficient in most of
the cases.
To summarize, we have shown nice convergence of
crystallographic and crosslinking data in solving the interaction
between IGF-1 and Imp-L2, and in clarification of postulated,
but not observed in solid state, hormone:IBP interfaces. Hence
this MS-based approach and methodology can be utilized in
other systems where contributing peptides from one interacting
partner can be clearly defined and the crosslinked product could
be isolated.
DATA AVAILABILITY STATEMENT
The datasets generated for this study are available on request to
the corresponding author.
AUTHOR CONTRIBUTIONS
PP performed the MS and analyzed the data. CV prepared
the recombinant Imp-L2. JR and JL prepared the recombinant
des(63-70)-IGF-1. JJ designed the experiment and edited
the manuscript. AB correlated the crosslinking data with
crystallography data and wrote the manuscript. IS designed and
performed the experiments, evaluated and interpreted the data,
and wrote the manuscript.
FUNDING
Medical Research Council Grants MR/K000179/1 and
MR/R009066/1, European Regional Development Fund; OP
RDE; Project: Chemical biology for drugging undruggable targets
(ChemBioDrug) (No. CZ.02.1.01/0.0/0.0/16_019/0000729).
Czech Infrastructure for Integrative Structural Biology
(LM2015043 CIISB for CMS BIOCEV funded by MEYS CR)
Institutional support was provided by project RVO 61388963.
ACKNOWLEDGMENTS
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